<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib43">
 <label>43</label>
 <element-citation publication-type="journal" id="sref43">
  <person-group person-group-type="author">
   <name>
    <surname>Pivot</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Gligorov</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Müller</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Curigliano</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Knoop</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Verma</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Jenkins</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Scotto</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Osborne</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Fallowfield</surname>
    <given-names>L.</given-names>
   </name>
   <collab>PrefHer Study Group</collab>
  </person-group>
  <article-title>Patients’ preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer study</article-title>
  <source>Ann. Oncol.</source>
  <volume>25</volume>
  <year>2014</year>
  <fpage>1979</fpage>
  <lpage>1987</lpage>
  <pub-id pub-id-type="pmid">25070545</pub-id>
 </element-citation>
</ref>
